$MU
Micron Technology Inc Stock $mu

$mu Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-K Financial Statement

#000072312514000195 Filed on October 27, 2014

Income Statement

Concept	2014 Q4	2013 Q3	2013 Q2
Revenue	$4.573B	$2.843B	$2.318B
YoY Change	13.14%	44.83%	6.72%
Cost Of Revenue	$2.935B	$2.135B	$1.762B
YoY Change	6.3%	22.42%	-9.08%
Gross Profit	$1.638B	$708.0M	$556.0M
YoY Change	27.87%	223.29%	137.61%
Gross Profit Margin	35.82%	24.9%	23.99%
Selling, General & Admin	$193.0M	$194.0M	$127.0M
YoY Change	9.66%	39.57%	-18.59%
% of Gross Profit	11.78%	27.4%	22.84%
Research & Development	$376.0M	$267.0M	$226.0M
YoY Change	17.5%	13.62%	-2.16%
% of Gross Profit	22.95%	37.71%	40.65%
Depreciation & Amortization	$643.0M	$450.0M	$421.0M
YoY Change	37.39%	-6.83%	-16.14%
% of Gross Profit	39.26%	63.56%	75.72%
Operating Expenses	$559.0M	$462.0M	$353.0M
YoY Change	12.7%	23.53%	-8.79%
Operating Profit	$1.079B	$207.0M	$149.0M
YoY Change	95.83%	-238.93%	-179.26%
Interest Expense	-$104.0M	-$60.00M	$54.00M
YoY Change	-202.97%	25.0%	-3.57%
% of Operating Profit	-9.64%	-28.99%	36.24%
Other Income/Expense, Net	$2.000M	-$1.000M	-$45.00M
YoY Change	-102.5%	-200.0%	2150.0%
Pretax Income	$953.0M	$1.678B	$52.00M
YoY Change	154.13%	-956.12%	-121.4%
Income Tax	$75.00M	$5.000M	-$1.000M
% Of Pretax Income	7.87%	0.3%	-1.92%
Net Earnings	$1.003B	$1.708B	$43.00M
YoY Change	180.17%	-802.88%	-113.44%
Net Earnings / Revenue	21.93%	60.08%	1.86%
Basic Earnings Per Share		$1.65	$0.04
Diluted Earnings Per Share	$839.3K	$1.51	$0.04
COMMON SHARES
Basic Shares Outstanding	1.073B shares	1.038B shares	1.024B shares
Diluted Shares Outstanding			1.047B shares

Balance Sheet

Concept	2014 Q4	2013 Q3	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.230B	$3.101B	$2.552B
YoY Change	9.3%	21.18%	9.76%
Cash & Equivalents	$3.764B	$2.880B	$2.440B
Short-Term Investments	$466.0M	$221.0M	$112.0M
Other Short-Term Assets	$331.0M	$276.0M	$99.00M
YoY Change	59.9%	181.63%	26.92%
Inventory	$2.448B	$2.649B	$1.732B
Prepaid Expenses
Receivables	$2.301B	$2.069B	$1.250B
Other Receivables	$362.0M	$260.0M	$253.0M
Total Short-Term Assets	$9.672B	$8.911B	$5.886B
YoY Change	3.23%	54.76%	4.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.132B	$7.626B	$6.830B
YoY Change	18.09%	7.36%	-4.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.080B	$396.0M	$272.0M
YoY Change	120.41%	1.8%	-32.51%
Other Assets	$446.0M	$439.0M	$389.0M
YoY Change	-9.72%	53.5%	2.91%
Total Long-Term Assets	$12.87B	$10.21B	$8.169B
YoY Change	23.45%	19.1%	-5.95%
TOTAL ASSETS
Total Short-Term Assets	$9.672B	$8.911B	$5.886B
Total Long-Term Assets	$12.87B	$10.21B	$8.169B
Total Assets	$22.54B	$19.12B	$14.06B
YoY Change	13.88%	33.43%	-1.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$961.0M	$1.048B	$736.0M
YoY Change	-17.44%	28.12%	-5.52%
Accrued Expenses	$364.0M	$267.0M	$216.0M
YoY Change	8.01%	-7.93%	-53.04%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.168B	$1.585B	$357.0M
YoY Change	-24.3%	607.59%	36.26%
Total Short-Term Liabilities	$4.419B	$4.125B	$2.342B
YoY Change	-2.08%	83.91%	7.58%
LONG-TERM LIABILITIES
Long-Term Debt	$4.661B	$4.452B	$3.267B
YoY Change	9.41%	46.54%	11.27%
Other Long-Term Liabilities	$969.0M	$535.0M	$420.0M
YoY Change	10.74%	-15.08%	-41.42%
Total Long-Term Liabilities	$969.0M	$535.0M	$3.687B
YoY Change	10.74%	-85.41%	0.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.419B	$4.125B	$2.342B
Total Long-Term Liabilities	$969.0M	$535.0M	$3.687B
Total Liabilities	$9.996B	$9.112B	$6.029B
YoY Change	3.61%	54.15%	3.41%
SHAREHOLDERS EQUITY
Retained Earnings	$3.713B	-$212.0M	-$1.920B
YoY Change	2846.83%	-84.88%	65.66%
Common Stock	$7.930B	$9.291B	$9.179B
YoY Change	-12.13%	2.98%	3.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.68B	$9.142B	$7.328B
YoY Change
Total Liabilities & Shareholders Equity	$22.54B	$19.12B	$14.06B
YoY Change	13.88%	33.43%	-1.82%

Cashflow Statement

Concept	2014 Q4	2013 Q3	2013 Q2
OPERATING ACTIVITIES
Net Income	$1.003B	$1.708B	$43.00M
YoY Change	180.17%	-802.88%	-113.44%
Depreciation, Depletion And Amortization	$643.0M	$450.0M	$421.0M
YoY Change	37.39%	-6.83%	-16.14%
Cash From Operating Activities	$1.592B	$717.0M	$624.0M
YoY Change	5.64%	59.33%	-9.04%
INVESTING ACTIVITIES
Capital Expenditures	-$669.0M	-$478.0M	-$203.0M
YoY Change	-200.0%	43.98%	-26.98%
Acquisitions
YoY Change
Other Investing Activities	-$407.0M	-$262.0M	$32.00M
YoY Change	1303.45%		-106.17%
Cash From Investing Activities	-$1.076B	-$740.0M	-$171.0M
YoY Change	781.97%	122.89%	-78.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-806.0M	463.0M	-74.00M
YoY Change	36.15%	208.67%	-135.58%
NET CHANGE
Cash From Operating Activities	1.592B	717.0M	624.0M
Cash From Investing Activities	-1.076B	-740.0M	-171.0M
Cash From Financing Activities	-806.0M	463.0M	-74.00M
Net Change In Cash	-290.0M	440.0M	379.0M
YoY Change	-136.57%	64.18%	290.72%
FREE CASH FLOW
Cash From Operating Activities	$1.592B	$717.0M	$624.0M
Capital Expenditures	-$669.0M	-$478.0M	-$203.0M
Free Cash Flow	$2.261B	$1.195B	$827.0M
YoY Change	169.81%	52.81%	-14.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2698000000	USD
CY2013Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2115000000	USD
CY2014Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	281000000	USD
CY2013Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	239000000	USD
CY2013Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	374000000	USD
CY2014Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	673000000	USD
CY2013Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1048000000	USD
CY2014Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1119000000	USD
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2524000000	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2069000000	USD
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14750000000	USD
CY2013Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13294000000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	56000000	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	63000000	USD
CY2013Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9187000000	USD
CY2014Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7879000000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	191000000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	91000000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	87000000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	115000000	USD
CY2013Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5000000	USD
CY2014Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3000000	USD
CY2013	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	122000000	USD
CY2012	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	81000000	USD
CY2014	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	167000000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	83000000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	88000000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	110000000	USD
CY2014Q3	us-gaap	Assets Assets	22498000000	USD
CY2013Q3	us-gaap	Assets Assets	19118000000	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	8911000000	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	10245000000	USD
CY2013Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	2283000000	USD
CY2014Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	2935000000	USD
CY2013Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	221000000	USD
CY2014Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	384000000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	835000000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	1281000000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2934000000	USD
CY2012	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	34000000	USD
CY2013Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	499000000	USD
CY2014Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	819000000	USD
CY2012	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-4.51
CY2013	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	3.69
CY2013	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	3.57
CY2012	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-4.51
CY2013	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	3825000000	USD
CY2012	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-4439000000	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	12494000000	USD
CY2012	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	11492000000	USD
CY2013	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	1484000000	USD
CY2013Q3	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	46000000	USD
CY2012	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
CY2013Q3	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	355000000	USD
CY2014	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	587000000	USD
CY2013	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	443000000	USD
CY2012	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	897000000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4150000000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2880000000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2459000000	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2160000000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	299000000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	421000000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1270000000	USD
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1044000000	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1073000000	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1044000000	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1073000000	shares
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	107000000	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	104000000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1084000000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1173000000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3038000000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	5000000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	34000000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-5000000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3072000000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1178000000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1089000000	USD
CY2012	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7266000000	USD
CY2013	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7226000000	USD
CY2014	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10921000000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3000000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-14000000	USD
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	17000000	USD
CY2012	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	22000000	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	46000000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	17000000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	8000000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	51000000	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2013Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	140000000	USD
CY2014Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	98000000	USD
CY2013Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	6037000000	USD
CY2014Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	6593000000	USD
CY2014Q3	us-gaap	Debt Current DebtCurrent	1638000000	USD
CY2013Q3	us-gaap	Debt Current DebtCurrent	1585000000	USD
CY2014	us-gaap	Debt Instrument Increase Decrease For Period Net DebtInstrumentIncreaseDecreaseForPeriodNet	1454000000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4000000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-9000000	USD
CY2012	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-25000000	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	81000000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-25000000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9000000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	77000000	USD
CY2014Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	502000000	USD
CY2013Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	508000000	USD
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	243000000	USD
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	309000000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4645000000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	982000000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3815000000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	870000000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1372000000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1490000000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	816000000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	861000000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	104000000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	169000000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	284000000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	313000000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	107000000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	152000000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	113000000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	8000000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3155000000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2443000000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	294000000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	291000000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	29000000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	74000000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	67000000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	14000000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	126000000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	115000000	USD
CY2014Q3	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	164000000	USD
CY2013Q3	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	196000000	USD
CY2014Q3	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	90000000	USD
CY2013Q3	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	116000000	USD
CY2012	us-gaap	Depreciation Depreciation	2053000000	USD
CY2013	us-gaap	Depreciation Depreciation	1721000000	USD
CY2014	us-gaap	Depreciation Depreciation	1993000000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1926000000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2222000000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2270000000	USD
CY2014	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-27000000	USD
CY2012	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-19000000	USD
CY2013	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-222000000	USD
CY2014	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, which will supersede nearly all existing revenue recognition guidance under U.S. GAAP.  The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.  This ASU will be effective for us in our first quarter of 2018.  Early adoption is not permitted. The ASU allows for either full retrospective or modified retrospective adoption. We are evaluating the transition method that will be elected and the potential effects of the adoption of this ASU on our financial statements.</font></div></div>
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.04
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.87
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.65
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.04
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.54
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.51
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.61
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.68
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	0	USD
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	0	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-28000000	USD
CY2014Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	456000000	USD
CY2014	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2014, 2013 and 2012 each contained 52 weeks. Fiscal year 2015 will contain 53 weeks, and the first quarter of fiscal 2015 will contain 14 weeks. All period references are to our fiscal periods unless otherwise indicated.</font></div></div>
CY2014Q3	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	8000000	USD
CY2013Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	267000000	USD
CY2014Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	275000000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y5M
CY2013	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
CY2014	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	119000000	USD
CY2012	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
CY2013Q3	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	1018000000	USD
CY2014Q3	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	2233000000	USD
CY2013Q3	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	1912000000	USD
CY2014Q3	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	1417000000	USD
CY2013	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	1000000	USD
CY2014	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	1576000000	USD
CY2012	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	-451000000	USD
CY2013	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	-203000000	USD
CY2012	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	-751000000	USD
CY2014	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	1371000000	USD
CY2013	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-188000000	USD
CY2012	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-793000000	USD
CY2014	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	1339000000	USD
CY2014Q3	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	2502000000	USD
CY2013Q3	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	2634000000	USD
CY2014Q3	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	254000000	USD
CY2013Q3	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	435000000	USD
CY2013	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	1788000000	USD
CY2014	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	3382000000	USD
CY2012	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	1798000000	USD
CY2013Q3	us-gaap	Equity Method Investments EquityMethodInvestments	396000000	USD
CY2014Q3	us-gaap	Equity Method Investments EquityMethodInvestments	971000000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	383000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	342000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	112000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	31000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	77000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	88000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	98000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	810000000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	769000000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	386000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	468000000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-229000000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-28000000	USD
CY2012	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6000000	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	3000000	USD
CY2012	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-5000000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-10000000	USD
CY2014	us-gaap	Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome	97000000	USD
CY2012	us-gaap	Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome	0	USD
CY2013	us-gaap	Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome	48000000	USD
CY2012	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2014	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-233000000	USD
CY2013	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2014	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	93000000	USD
CY2012	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	0	USD
CY2013	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	48000000	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-31000000	USD
CY2012	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-195000000	USD
CY2012	us-gaap	Gross Profit GrossProfit	968000000	USD
CY2014	us-gaap	Gross Profit GrossProfit	5437000000	USD
CY2013	us-gaap	Gross Profit GrossProfit	1847000000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	708000000	USD
CY2012Q4	us-gaap	Gross Profit GrossProfit	217000000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	366000000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	556000000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	1281000000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	1403000000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	1385000000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	1368000000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	446000000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1028000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	114000000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	839000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2619000000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	274000000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-754000000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1285000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2733000000	USD
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-83000000	USD
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	474000000	USD
CY2012	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-294000000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8000000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17000000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	128000000	USD
CY2013	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	141000000	USD
CY2012	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	52000000	USD
CY2014	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	286000000	USD
CY2014	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.24
CY2013	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.13
CY2012	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.05
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	368000000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-544000000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	418000000	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-474000000	USD
CY2012	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-77000000	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-339000000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	450000000	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-264000000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	956000000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1000000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	19000000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	5000000	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-9000000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-6000000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	39000000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-2000000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	152000000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-52000000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	2000000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	11000000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	36000000	USD
CY2012	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-13000000	USD
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-4000000	USD
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	43000000	USD
CY2014Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	104000000	USD
CY2013Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	74000000	USD
CY2012	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-3000000	USD
CY2014	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-68000000	USD
CY2013	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	7000000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-194000000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-258000000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-83000000	USD
CY2012	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	182000000	USD
CY2013	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	22000000	USD
CY2014	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	671000000	USD
CY2014	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	243000000	USD
CY2013	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-15000000	USD
CY2012	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-89000000	USD
CY2012	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	63000000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-29000000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-10000000	USD
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	409000000	USD
CY2012	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-238000000	USD
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	518000000	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-536000000	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-5000000	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2014	us-gaap	Interest And Debt Expense InterestAndDebtExpense	205000000	USD
CY2014Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	17000000	USD
CY2013Q4	us-gaap	Interest And Debt Expense InterestAndDebtExpense	92000000	USD
CY2014Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	80000000	USD
CY2013Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	31000000	USD
CY2014Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	16000000	USD
CY2012	us-gaap	Interest Expense InterestExpense	179000000	USD
CY2013	us-gaap	Interest Expense InterestExpense	231000000	USD
CY2014	us-gaap	Interest Expense InterestExpense	352000000	USD
CY2013	us-gaap	Interest Paid Net InterestPaidNet	107000000	USD
CY2014	us-gaap	Interest Paid Net InterestPaidNet	163000000	USD
CY2012	us-gaap	Interest Paid Net InterestPaidNet	72000000	USD
CY2014Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	898000000	USD
CY2013Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	796000000	USD
CY2014Q3	us-gaap	Inventory Net InventoryNet	2455000000	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	2649000000	USD
CY2013Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	134000000	USD
CY2014Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	185000000	USD
CY2014Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1372000000	USD
CY2013Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1719000000	USD
CY2012	us-gaap	Investment Income Net InvestmentIncomeNet	8000000	USD
CY2014	us-gaap	Investment Income Net InvestmentIncomeNet	23000000	USD
CY2013	us-gaap	Investment Income Net InvestmentIncomeNet	14000000	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	48000000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	57000000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	41000000	USD
CY2014Q3	us-gaap	Liabilities Liabilities	10868000000	USD
CY2013Q3	us-gaap	Liabilities Liabilities	9112000000	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22498000000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19118000000	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4811000000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4125000000	USD
CY2013Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4452000000	USD
CY2014Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4955000000	USD
CY2014	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Rambus</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 5, 2004, Rambus, Inc. ("Rambus") filed a complaint in the Superior Court of the State of California (San Francisco County) against us and other DRAM suppliers which alleged that the defendants harmed Rambus by engaging in concerted and unlawful efforts affecting Rambus DRAM by eliminating competition and stifling innovation in the market for computer memory technology and computer memory chips.  Rambus' complaint alleged various causes of action under California state law including, among other things, a conspiracy to restrict output and fix prices, a conspiracy to monopolize, intentional interference with prospective economic advantage, and unfair competition. Rambus sought a judgment for damages of approximately $3.90 billion, joint and several liability, trebling of damages awarded, punitive damages, a permanent injunction enjoining the defendants from the conduct alleged in the complaint, interest, and attorneys' fees and costs. Trial began on June 20, 2011, and the case went to the jury on September 21, 2011. On November 16, 2011, the jury found for us on all claims. On April 2, 2012, Rambus filed a notice of appeal to the California 1st District Court of Appeal.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We were engaged in litigation with Rambus relating to certain of Rambus' patents and certain of our claims and defenses. Our lawsuits with Rambus related to patent matters were pending in the U.S. District Court for the District of Delaware, U.S. District Court for the Northern District of California, Germany, France, and Italy.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2013, we settled all pending litigation between us and Rambus, including all antitrust and patent matters.  We also entered into a seven-year term patent cross-license agreement with Rambus that allows us to avoid costs of patent-related litigation during the term.  We agreed to pay Rambus up to $10 million per quarter over seven years, for a total of $280 million, beginning in the second quarter of 2014.  The primary benefits we received from these arrangements were (1) the settlement and termination of all existing litigation, (2) the avoidance of future litigation expenses and (3) the avoidance of future management and customer disruptions.  As a result, other operating expense for the first quarter of 2014 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Patent Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including MMJ and Elpida Memory (USA) Inc.  On August 22, 2013, the plaintiffs filed a third amended complaint. The third amended complaint alleges that certain of our DRAM and image sensor products infringe four U.S. patents and that certain MMJ and Elpida Memory (USA) Inc. DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. Trial currently is scheduled for February 22, 2016. On March 23, 2012, MMJ and Elpida Memory (USA) Inc. filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against MMJ and Elpida Memory (USA) Inc. Accordingly, the plaintiffs' case against MMJ and Elpida Memory (USA) was stayed.  On June 25, 2013, the U.S. Bankruptcy Court for the District of Delaware entered its Order (1) Granting Recognition of the Japanese Reorganization Plan of MMJ and the Tokyo District Court's Confirmation Orders, (2) Entrusting MMJ's U.S. Assets to Foreign Representatives and Approving Certain Plan Transactions, (3) Granting Permanent Injunction, and (4) Granting Related Relief (the "Recognition Order").  Pursuant to the Recognition Order, the plaintiffs are permanently enjoined from continuing their case against MMJ and Elpida Memory (USA) Inc. in respect of any claim or claims arising prior to the commencement of the Japan Proceeding (as defined in the Recognition Order).</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 5, 2011, the Board of Trustees for the University of Illinois (the "University") filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">inter-partes</font><font style="font-family:inherit;font-size:10pt;"> review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The Patent Trial and Appeal Board ("PTAB") held a hearing in connection with the three petitions on December 9, 2013. On March 10, 2014, the PTAB issued written decisions finding that each and every claim in the three patents in suit is invalid, and cancelled all claims. The University has appealed the PTAB rulings to the U.S. Court of Appeals for the Federal Circuit.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. Trial is currently scheduled for August 21, 2015.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 7, 2007, Tessera, Inc. filed a patent infringement action against MMJ, Elpida Memory (USA) Inc., and numerous other defendants, in the United States District Court for the Eastern District of Texas. The complaint alleges that certain MMJ and Elpida Memory (USA) Inc. products infringe four U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. Prior to answering the complaint, MMJ and Elpida Memory (USA) Inc. and other defendants filed motions to stay the case pending final resolution of a case before the International Trade Commission ("ITC") against MMJ and Elpida Memory (USA) Inc. and other respondents, alleging infringement of the same patents asserted in the Eastern District of Texas case (In The Matter of Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same (III), ITC No. 337-TA-630 (the "ITC Action")). On February 25, 2008, the Eastern District of Texas Court granted the defendants' motion to stay the action. On December 29, 2009, the ITC issued a Notice of Final Determination in the ITC Action finding no violation by MMJ and Elpida Memory (USA) Inc. Tessera, Inc. subsequently appealed the matter to the U.S. Court of Appeals for the Federal Circuit. On May 23, 2011, the Federal Circuit affirmed the ITC's Final Determination. Additionally, by operation of the Recognition Order, plaintiff in that action is permanently enjoined from continuing its case against MMJ and Elpida Memory (USA) in respect of any claim or claims arising prior to the commencement of the Japan Proceeding (as defined in the Recognition Order). On July 30, 2014, we entered into a five-year term patent cross-license agreement with Tessera, which also settled the pending litigation against MMJ and Elpida Memory (USA). The agreement, which requires us to make quarterly payments over its term, gives us “life-of-product” protection for specifically identified DRAM products and a term license for certain other products. We capitalized an intangible asset for the term of the agreement and also recorded a $66 million charge to cost of goods sold in the fourth quarter of 2014.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Among other things, the above lawsuits pertain to certain of our DDR, DDR2, DDR3, SDR SDRAM, PSRAM, RLDRAM, LPDRAM, NAND Flash, image sensor products and certain other memory products we manufacture, which account for a significant portion of our net sales.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Except for the Tessera matter discussed above, we are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Antitrust Matters</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At least sixty-eight purported class action price-fixing lawsuits have been filed against us and other DRAM suppliers in various federal and state courts in the United States and in Puerto Rico on behalf of indirect purchasers alleging a conspiracy to increase DRAM prices in violation of federal and state antitrust laws and state unfair competition law, and/or unjust enrichment relating to the sale and pricing of DRAM products during the period from April 1999 through at least June 2002. The complaints seek joint and several damages, trebled, in addition to restitution, costs and attorneys' fees. A number of these cases were removed to federal court and transferred to the U.S. District Court for the Northern District of California for consolidated pre-trial proceedings. In July 2006, the Attorneys General for approximately forty U.S. states and territories filed suit in the U.S. District Court for the Northern District of California. The complaints allege, among other things, violations of the Sherman Act, Cartwright Act, and certain other states' consumer protection and antitrust laws and seek joint and several damages, trebled, as well as injunctive and other relief. On October 3, 2008, the California Attorney General filed a similar lawsuit in California Superior Court, purportedly on behalf of local California government entities, alleging, among other things, violations of the Cartwright Act and state unfair competition law. On June 23, 2010, we executed a settlement agreement resolving these purported class-action indirect purchaser cases and the pending cases of the Attorneys General relating to alleged DRAM price-fixing in the United States. Subject to certain conditions, we agreed to pay approximately $67 million in aggregate in three equal installments over a two-year period. We paid the full amount into an escrow account by the end of the first quarter of 2013 in accordance with the settlement agreement.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 21, 2010, the Brazil Secretariat of Economic Law of the Ministry of Justice ("SDE") announced that it had initiated an investigation relating to alleged anticompetitive activities within the DRAM industry. The SDE's Notice of Investigation names various DRAM manufacturers and certain executives, including us, and focuses on the period from July 1998 to June 2002.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss, except as noted in the above discussion of the U.S. indirect purchaser cases. The final resolution of these alleged violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Securities Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 12, 2013, seven former shareholders of Elpida (now known as MMJ) filed a complaint against Messrs. Sakamoto, Adachi, Gomi, Shirai, Tsay-Jiu, Wataki, Kinoshita, and Takahasi in their capacity as members of the board of directors of MMJ as of February 2013. The complaint alleges that the defendants engaged in various acts and misrepresentations to hide the financial condition of MMJ and deceive shareholders prior to MMJ filing a petition for corporate reorganization on February 27, 2013. The plaintiffs seek joint and several damages equal to the market value of shares owned by each of the plaintiffs on February 23, 2013, along with attorneys' fees and interest. At a hearing on September 25, 2013, the plaintiffs withdrew the complaint against Mr. Tsay-Jiu.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of this matter and therefore cannot estimate the range of possible loss.  The final resolution of this matter could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Qimonda</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda insolvency proceedings, filed suit against MTI and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008 pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera Memories, Inc. (the "Inotera Shares"), representing approximately 55% of our total shares in Inotera, and seeks an order requiring us to retransfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following a series of hearings with pleadings, arguments and witnesses on behalf of the Qimonda estate, on March 13, 2014, the Court issued judgments:  (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on such shares and all other benefits; (4) denying Qimonda’s claims against Micron Technology for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are cancelled. In addition, the Court issued interlocutory judgments ordering, among other things:  (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by it and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by it from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court. A hearing on the matter is scheduled for February 2, 2015.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera Shares or equivalent monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation or financial condition.  As of August 28, 2014, the Inotera Shares had a carrying value in equity method investments for purposes of our financial reporting of $505 million and a market value of $2.06 billion.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations or financial condition.</font></div></div>
CY2013Q3	us-gaap	Minority Interest MinorityInterest	864000000	USD
CY2014Q3	us-gaap	Minority Interest MinorityInterest	802000000	USD
CY2013	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	37000000	USD
CY2014	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	18000000	USD
CY2012	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	391000000	USD
CY2014	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	146000000	USD
CY2012	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	466000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1948000000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	322000000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	497000000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2312000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2453000000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1712000000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1811000000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2114000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	5699000000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	3045000000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	1190000000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-1032000000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-286000000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-275000000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	43000000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	1708000000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	731000000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	1150000000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	358000000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	806000000	USD
CY2012	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000000	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	34000000	USD
CY2014	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	3043000000	USD
CY2012	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1032000000	USD
CY2013	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	1190000000	USD
CY2013	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	168000000	USD
CY2013	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	11000000	USD
CY2014	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	102000000	USD
CY2012	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	197000000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	3087000000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-612000000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	236000000	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-97000000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23000000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	207000000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	149000000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	828000000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	869000000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	551000000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	839000000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	116000000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	22000000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	12000000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	13000000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	14000000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	18000000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	37000000	USD
CY2014Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	10970000000	USD
CY2013	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	113000000	USD
CY2012	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	78000000	USD
CY2014	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	168000000	USD
CY2013Q3	us-gaap	Other Assets Current OtherAssetsCurrent	276000000	USD
CY2014Q3	us-gaap	Other Assets Current OtherAssetsCurrent	350000000	USD
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	439000000	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	497000000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-24000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	2000000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-18000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-9000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-9000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5000000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-16000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2000000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-58000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7000000	USD
CY2013	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	924000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-16000000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-3000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1000000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	31000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2014Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1102000000	USD
CY2013Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	535000000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-218000000	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8000000	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29000000	USD
CY2014	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-232000000	USD
CY2012	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-32000000	USD
CY2013	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	8000000	USD
CY2013Q3	us-gaap	Other Receivables OtherReceivables	186000000	USD
CY2014Q3	us-gaap	Other Receivables OtherReceivables	278000000	USD
CY2014	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-96000000	USD
CY2013	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-31000000	USD
CY2012	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-43000000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	76000000	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6000000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5000000	USD
CY2014	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	10000000	USD
CY2013	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	37000000	USD
CY2012	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	391000000	USD
CY2012	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	564000000	USD
CY2014	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	1063000000	USD
CY2013	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2014	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2012	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	187000000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1699000000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1244000000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2658000000	USD
CY2012	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	466000000	USD
CY2014	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	18000000	USD
CY2013	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2014	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior period amounts to conform to current period presentation. Certain deferred tax assets in prior years were corrected with corresponding changes in the valuation allowance, resulting in no change to net deferred tax assets. Changes in these items were not material for any period presented.</font></div></div>
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1065000000	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2212000000	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1121000000	USD
CY2012	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5000000	USD
CY2014	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	265000000	USD
CY2013	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	150000000	USD
CY2013	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	11000000	USD
CY2014	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	102000000	USD
CY2012	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	197000000	USD
CY2013	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-87000000	USD
CY2014	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-115000000	USD
CY2012	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-141000000	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	557000000	USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	152000000	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	678000000	USD
CY2014	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	355000000	USD
CY2012	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	149000000	USD
CY2013	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	526000000	USD
CY2012	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2014	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	105000000	USD
CY2013	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2014	us-gaap	Profit Loss ProfitLoss	3079000000	USD
CY2012	us-gaap	Profit Loss ProfitLoss	-1031000000	USD
CY2013	us-gaap	Profit Loss ProfitLoss	1194000000	USD
CY2013Q3	us-gaap	Profit Loss ProfitLoss	1710000000	USD
CY2012Q4	us-gaap	Profit Loss ProfitLoss	-275000000	USD
CY2013Q2	us-gaap	Profit Loss ProfitLoss	43000000	USD
CY2013Q1	us-gaap	Profit Loss ProfitLoss	-284000000	USD
CY2013Q4	us-gaap	Profit Loss ProfitLoss	381000000	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	1151000000	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	806000000	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	741000000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23432000000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20920000000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8682000000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7626000000	USD
CY2014Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	2906000000	USD
CY2013Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	2329000000	USD
CY2014	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	9000000	USD
CY2014	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	3843000000	USD
CY2013	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	743000000	USD
CY2012	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	203000000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	918000000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	931000000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1371000000	USD
CY2013Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	556000000	USD
CY2014Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2014	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	-17000000	USD
CY2012	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	-6000000	USD
CY2013	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	112000000	USD
CY2012	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	10000000	USD
CY2014	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	40000000	USD
CY2013	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	126000000	USD
CY2013Q3	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	32000000	USD
CY2013Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	60000000	USD
CY2012Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	-21000000	USD
CY2013Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	55000000	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2729000000	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-212000000	USD
CY2014	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	14000000	USD
CY2012	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	609000000	USD
CY2013	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	126000000	USD
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	8234000000	USD
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	9073000000	USD
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	16358000000	USD
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	1834000000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	2078000000	USD
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	2843000000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	2318000000	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	4107000000	USD
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	4042000000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	4227000000	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	3982000000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	620000000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	562000000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	707000000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	91000000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	87000000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	115000000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1000000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	8.75
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	7000000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.88
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.43
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.23
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	13000000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	13000000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	15.08
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	6.49
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	6000000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	32000000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	17000000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	115000000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	6.29
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed	Black-Scholes
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.009	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.66	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.48	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.59	pure
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	161000000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	99000000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	14000000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.88
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	103000000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6000000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	421000000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3000000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9.27
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	12000000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.34
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.64
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.18
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1078000000	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	48000000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	71000000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.41
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.57
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.27
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	22.61
CY2014Q3	us-gaap	Share Price SharePrice	32.81
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y1M
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y11M
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y1M
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	362000000	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y5M
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M
CY2012Q1	us-gaap	Significant Acquisitions And Disposals Acquisition Costs Or Sale Proceeds SignificantAcquisitionsAndDisposalsAcquisitionCostsOrSaleProceeds	35000000	USD
CY2014Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Lower Bound SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeLowerBound	0	USD
CY2014Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Upper Bound SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound	77000000	USD
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	32000000	shares
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	138000000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	266000000	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6000000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	150000000	USD
CY2014	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	162000000	USD
CY2012	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	6000000	USD
CY2013	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	5000000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	9142000000	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	10771000000	USD
CY2014Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11573000000	USD
CY2013Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10006000000	USD
CY2012Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8417000000	USD
CY2011Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9852000000	USD
CY2014Q3	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	443000000	USD
CY2013Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	47000000	USD
CY2014Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	71000000	USD
CY2014Q3	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	4910000000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	78000000	USD
CY2012Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	77000000	USD
CY2014Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	228000000	USD
CY2011Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	121000000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation	9000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	14000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	8000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	1000000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	29000000	USD
CY2014Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	19000000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	16000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation	1000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2000000	USD
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1060000000	shares
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2014Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	66000000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	63000000	USD
CY2012Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	66000000	USD
CY2013	mu	Adjustments To Additional Paid In Capital Option Indexed To Issuers Equity AdjustmentsToAdditionalPaidInCapitalOptionIndexedToIssuersEquity	-24000000	USD
CY2012Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	12000000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	1000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4000000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	6000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	152000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation	4000000	USD
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates:</font><font style="font-family:inherit;font-size:10pt;"> The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures.  Estimates and judgments are based on historical experience, forecasted events and various other assumptions that we believe to be reasonable under the circumstances.  Estimates and judgments may differ under different assumptions or conditions.  We evaluate our estimates and judgments on an ongoing basis.  Actual results could differ from estimates.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-712000000	USD
CY2012	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	138000000	shares
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	35000000	shares
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	991000000	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1198000000	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1057000000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1022000000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	991000000	shares
CY2012	mu	Adjustments To Additional Paid In Capital Option Indexed To Issuers Equity AdjustmentsToAdditionalPaidInCapitalOptionIndexedToIssuersEquity	-102000000	USD
CY2014	mu	Adjustments To Additional Paid In Capital Option Indexed To Issuers Equity AdjustmentsToAdditionalPaidInCapitalOptionIndexedToIssuersEquity	86000000	USD
CY2014Q3	mu	Available For Sale Securities Debt Maturities After Four Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFourYearsFairValue	29000000	USD
CY2014Q3	mu	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	438000000	USD
CY2014Q3	mu	Available For Sale Securities Debt Maturities After Two Through Four Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTwoThroughFourYearsFairValue	351000000	USD
CY2013	mu	Business Acquisition Componentof Pro Forma Net Income Loss Forgiveness Of Debt Income BusinessAcquisitionComponentofProFormaNetIncomeLossForgivenessOfDebtIncome	1690000000	USD
CY2012	mu	Business Acquisition Componentof Pro Forma Net Income Loss Loss For Impairment Of Long Lived Assets BusinessAcquisitionComponentofProFormaNetIncomeLossLossForImpairmentOfLongLivedAssets	2830000000	USD
CY2012	mu	Business Acquisition Pro Forma Net Income Loss Attributable To Parent BusinessAcquisitionProFormaNetIncomeLossAttributableToParent	-4471000000	USD
CY2013	mu	Business Acquisition Pro Forma Net Income Loss Attributable To Parent BusinessAcquisitionProFormaNetIncomeLossAttributableToParent	3770000000	USD
CY2014	mu	Business Combination Provisional Information Initial Accounting Incomplete Adjustment To Bargain Purchase Gain Recognized Amount BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentToBargainPurchaseGainRecognizedAmount	-33000000	USD
CY2014	mu	Cash Increase Decrease Net Change As A Result Of Debt Restructure Activities CashIncreaseDecreaseNetChangeAsAResultOfDebtRestructureActivities	-485000000	USD
CY2013Q3	mu	Convertible Debt Equity ConvertibleDebtEquity	0	USD
CY2014Q3	mu	Convertible Debt Equity ConvertibleDebtEquity	57000000	USD
CY2012	mu	Debt Conversion Converted Instrument Amount Net Of Unamortized Issuance Cost DebtConversionConvertedInstrumentAmountNetOfUnamortizedIssuanceCost	138000000	USD
CY2013	mu	Debt Conversion Converted Instrument Amount Net Of Unamortized Issuance Cost DebtConversionConvertedInstrumentAmountNetOfUnamortizedIssuanceCost	0	USD
CY2014	mu	Debt Conversion Converted Instrument Amount Net Of Unamortized Issuance Cost DebtConversionConvertedInstrumentAmountNetOfUnamortizedIssuanceCost	0	USD
CY2012	mu	Debt Exchange Convertible Debt Face Amount DebtExchangeConvertibleDebtFaceAmount	0	USD
CY2013	mu	Debt Exchange Convertible Debt Face Amount DebtExchangeConvertibleDebtFaceAmount	0	USD
CY2014	mu	Debt Exchange Convertible Debt Face Amount DebtExchangeConvertibleDebtFaceAmount	756000000	USD
CY2014	mu	Debt Instrument Increase Decrease Net Equity Component DebtInstrumentIncreaseDecreaseNetEquityComponent	-1691000000	USD
CY2013	mu	Debt Instrument Increase Decrease Net Equity Component DebtInstrumentIncreaseDecreaseNetEquityComponent	57000000	USD
CY2014	mu	Debt Instrument Increase Decrease Net Principal DebtInstrumentIncreaseDecreaseNetPrincipal	1371000000	USD
CY2013Q3	mu	Deferred Tax Assets Operating Loss And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards	4048000000	USD
CY2014Q3	mu	Deferred Tax Assets Operating Loss And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards	3162000000	USD
CY2014	mu	Depreciation And Amortization Expense Included In Operating Income Loss DepreciationAndAmortizationExpenseIncludedInOperatingIncomeLoss	2102000000	USD
CY2012	mu	Depreciation And Amortization Expense Included In Operating Income Loss DepreciationAndAmortizationExpenseIncludedInOperatingIncomeLoss	2144000000	USD
CY2013	mu	Depreciation And Amortization Expense Included In Operating Income Loss DepreciationAndAmortizationExpenseIncludedInOperatingIncomeLoss	1813000000	USD
CY2012	mu	Depreciationand Amortizationof Intangible Assets DepreciationandAmortizationofIntangibleAssets	2141000000	USD
CY2013	mu	Depreciationand Amortizationof Intangible Assets DepreciationandAmortizationofIntangibleAssets	1804000000	USD
CY2014	mu	Depreciationand Amortizationof Intangible Assets DepreciationandAmortizationofIntangibleAssets	2103000000	USD
CY2013Q3	mu	Diameter Of Wafer Used In Production DiameterOfWaferUsedInProduction	200	mm
CY2014	mu	Dilutive Securities Effecton Basic Earnings Per Share Equity Method Dilutive Effects DilutiveSecuritiesEffectonBasicEarningsPerShareEquityMethodDilutiveEffects	-2000000	USD
CY2013	mu	Dilutive Securities Effecton Basic Earnings Per Share Equity Method Dilutive Effects DilutiveSecuritiesEffectonBasicEarningsPerShareEquityMethodDilutiveEffects	0	USD
CY2012	mu	Dilutive Securities Effecton Basic Earnings Per Share Equity Method Dilutive Effects DilutiveSecuritiesEffectonBasicEarningsPerShareEquityMethodDilutiveEffects	0	USD
CY2014Q3	mu	Equipment Purchase Contracts EquipmentPurchaseContracts	166000000	USD
CY2013Q3	mu	Equipment Purchase Contracts EquipmentPurchaseContracts	182000000	USD
CY2012	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	0	USD
CY2014	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	-184000000	USD
CY2013	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	-31000000	USD
CY2012	mu	Income Tax Reconciliation Gain On Acquisition Of Business IncomeTaxReconciliationGainOnAcquisitionOfBusiness	0	USD
CY2013	mu	Income Tax Reconciliation Gain On Acquisition Of Business IncomeTaxReconciliationGainOnAcquisitionOfBusiness	-520000000	USD
CY2014	mu	Income Tax Reconciliation Gain On Acquisition Of Business IncomeTaxReconciliationGainOnAcquisitionOfBusiness	11000000	USD
CY2014	mu	Income Tax Reconciliation Transaction Costs IncomeTaxReconciliationTransactionCosts	0	USD
CY2013	mu	Income Tax Reconciliation Transaction Costs IncomeTaxReconciliationTransactionCosts	38000000	USD
CY2012	mu	Income Tax Reconciliation Transaction Costs IncomeTaxReconciliationTransactionCosts	0	USD
CY2014Q3	mu	Net Tax Benefits Not Recordedas Deferred Tax Assets Compensationand Benefits Sharebased Compensation Cost NetTaxBenefitsNotRecordedasDeferredTaxAssetsCompensationandBenefitsSharebasedCompensationCost	207000000	USD
CY2013	mu	Noncash Transaction Value Of Consideration Given To Acquire Minority Interest NoncashTransactionValueOfConsiderationGivenToAcquireMinorityInterest	0	USD
CY2012	mu	Noncash Transaction Value Of Consideration Given To Acquire Minority Interest NoncashTransactionValueOfConsiderationGivenToAcquireMinorityInterest	0	USD
CY2014	mu	Noncash Transaction Value Of Consideration Given To Acquire Minority Interest NoncashTransactionValueOfConsiderationGivenToAcquireMinorityInterest	127000000	USD
CY2013	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	-6000000	USD
CY2012	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	35000000	USD
CY2014	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	8000000	USD
CY2014	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	11000000	USD
CY2012	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	-27000000	USD
CY2013	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	5000000	USD
CY2014	mu	Payments For Derivative And Hedge Investing Activities PaymentsForDerivativeAndHedgeInvestingActivities	26000000	USD
CY2013	mu	Payments For Derivative And Hedge Investing Activities PaymentsForDerivativeAndHedgeInvestingActivities	253000000	USD
CY2012	mu	Payments For Derivative And Hedge Investing Activities PaymentsForDerivativeAndHedgeInvestingActivities	62000000	USD
CY2013	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	214000000	USD
CY2014	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	479000000	USD
CY2012	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	172000000	USD
CY2014	mu	Reclassification Adjustment For Convertible Debt In Mezzanine ReclassificationAdjustmentForConvertibleDebtInMezzanine	57000000	USD
CY2014Q3	mu	Senior Notesand Capital Leases SeniorNotesandCapitalLeases	1570000000	USD
CY2014Q3	mu	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Expected To Vest Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionExpectedToVestNumber	13000000	shares
CY2014Q3	mu	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue	14.91
CY2014Q3	mu	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Subject To Outstanding Awards ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesSubjectToOutstandingAwards	62000000	shares
CY2014Q3	mu	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestIntrinsicValue	692000000	USD
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014Q3	mu	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber	33000000	shares
CY2014Q3	mu	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice	11.92
CY2014	mu	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm	P4Y3M
CY2014Q3	mu	Total Basis Differences For Investments In Indefinitely Reinvested Foreign Subsidiaries TotalBasisDifferencesForInvestmentsInIndefinitelyReinvestedForeignSubsidiaries	6550000000	USD
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-28
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-08-28
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0000723125
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1073455204	shares
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q1	dei	Entity Public Float EntityPublicFloat	21300000000	USD
CY2014	dei	Entity Registrant Name EntityRegistrantName	MICRON TECHNOLOGY INC
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes

Files In Submission

Name	View Source	Status
0000723125-14-000195-index-headers.html	Edgar Link	pending
0000723125-14-000195-index.html	Edgar Link	pending
0000723125-14-000195.txt	Edgar Link	pending
0000723125-14-000195-xbrl.zip	Edgar Link	pending
a2013q4_chart-42352a02.jpg	Edgar Link	pending
a2014q4.htm	Edgar Link	pending
a2014q4ex211subsidiariesof.htm	Edgar Link	pending
a2014q4ex231pwcconsent.htm	Edgar Link	pending
a2014q4ex31-1ceocert.htm	Edgar Link	pending
a2014q4ex31-2cfocert.htm	Edgar Link	pending
a2014q4ex32-1906ceocert.htm	Edgar Link	pending
a2014q4ex32-2906cfocert.htm	Edgar Link	pending
a2014q4exhibit10-10.htm	Edgar Link	pending
a2014q4exhibit109.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
micronlogo.jpg	Edgar Link	pending
mu-20140828.xml	Edgar Link	completed
mu-20140828.xsd	Edgar Link	pending
mu-20140828_cal.xml	Edgar Link	unprocessable
mu-20140828_def.xml	Edgar Link	unprocessable
mu-20140828_lab.xml	Edgar Link	unprocessable
mu-20140828_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MU
Micron Technology Inc Stock $mu

2014 Q4 Form 10-K Financial Statement

#000072312514000195 Filed on October 27, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU Micron Technology Inc Stock $mu

2014 Q4 Form 10-K Financial Statement

#000072312514000195 Filed on October 27, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU
Micron Technology Inc Stock $mu